SAM #PAR260040_N4485226CA002

Malaria and Leishmaniasis Surveillance Services in Amazonas, Peru

This opportunity is for a contractor to conduct malaria and leishmaniasis surveillance in Amazonas, Peru, supporting U.S. military health monitoring. - Agency: Armed Forces Health Surveillance Division (AFHSD), Global Emerging Infections Surveillance and Response Branch (GEIS) - Scope of work: - Project management and oversight - Development of human subject research protocols - Securing ethical and regulatory approvals - Fieldwork in Chachapoyas, Amazonas, Peru - Enrollment and sample collection from at least 150 human subjects - Laboratory screening using microscopy and molecular methods (DNA extraction, LAMP, real-time PCR) - Provision of clinical samples and laboratory testing - Shipment of samples to NAMRU SOUTH (one shipment per year) - Data analysis and reporting - Contractor must supply all necessary materials and cover shipment costs - No specific OEMs, products, or part numbers are listed; focus is on specialized research and laboratory services - Offerors should propose their own labor mix and technical approach - Place of performance: Chachapoyas, Amazonas, Peru - Period of performance: 5 months, August to December, with monthly reporting - No option years or annual subscription indicated

Description

Study called Malaria and leishmaniasis surveillance in Amazonas - Peru.

The contractor shall provide services including (but not limited to) i) project management, ii) write a human subject protocol, iii) obtain the respective ethical and regulatory approvals for conducting human subject research, iv) conduct fieldwork, collect samples and clinical and epidemiological data and v) conduct screening using microscopy and molecular laboratory methods for detection of Plasmodium and leishmania on collected specimens.

The Offeror is encouraged to propose a labor mix and level of effort based on their technical approach. The contractor shall provide general classes of services including (but not limited to) project management, provision of clinical samples, laboratory testing, shipment of samples, data analysis and reporting.

The time of the study is 5 months, from August to December 2026.

View original listing